Follow Perspective Therapeutics. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
5 Stories in coverage 0 Programs 33 recruiting Registered trials Nov 13 Latest story
Timeline 5 Pipeline 0 Trials 3
All5 Regulatory2 Trials and readouts4 Filings and people1
Details
Headquarters Seattle, WA Incorporated Delaware Industry Pharmaceutical Preparations Formerly IsoRay, Inc. (to 2023); Isoray, Inc. (to 2023); CENTURY PARK PICTURES CORP (to 2005) Also known as CATX, CENTURY PARK PICTURES CORP, IsoRay, Inc., Perspective Therapeutics, Inc. How the company describes itself Perspective Therapeutics develops radiopharmaceutical therapies using alpha-emitting isotope 212Pb paired with imaging agents for personalized cancer treatment. The company has clinical-stage programs for neuroendocrine tumors, melanoma, and solid tumors, supported by proprietary 224Ra/212Pb generator manufacturing technology. source